Blood component transfusion is an important and lifesaving Emergency Department (ED) procedure. It is not however risk-free and careful consideration of its clinical benefit for each individual patient is therefore essential. In 2008, we audited the patterns of blood component usage in 2007 within our ED. This work revealed that whilst 3209 units of blood component were ordered only 39.5% were transfused, and 9.5% were unaccounted for. This was the first and only published detailed look at ED blood transfusion practices. We had to address our poor traceability (i.e. unaccounted for units), our high blood usage, and our ordering of units which were then not transfused as this can lead to wastage. Firstly, better links between the ED and the Scottish National Blood Transfusion Service (SNBTS) were established. A set of improvement measures were then implemented including better ED medical and nursing staff education, monthly traceability reports sent to the ED clinical management teams, the introduction of an ED transfusion guideline, moving our blood fridge into the resuscitation room, having a named ED transfusion consultant and ED transfusion link nurse, ED consultant representation on the Hospital Transfusion Group and finally increasing awareness of ED emergency transfusion with a rotational thromboelastometry (ROTEM) research programme. In 2012, we reaudited our practice looking at our blood component usage in 2011. There was a 64% reduction in blood component ordering (3209 vs. 1034 units), a 39% reduction in blood component transfusion (1131 vs. 687 units), a 68% increase in the proportion of ordered units that were transfused and a 96% reduction in unaccounted units (289 vs. 9 units) between 2007 and 2011. In attempting to cost the savings resulting from our changes we showed that SNBTS spent £306,437 less in 2011 compared to 2007 on handling and issuing ED transfusion requests.
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Our improvements are immediately generalizable across the UK and the potential savings to the NHS are enormous.
Problem
Blood component transfusion can be a vital and lifesaving intervention when given appropriately. However transfusion is not risk-free, and therefore careful consideration of its clinical benefit for each individual patient is essential. Supply of blood components is a finite resource, relying on continuous public donation to maintain adequate stocks, as components have a limited period of viability.
Blood and its various components is therefore an extremely valuable commodity, requiring careful allocation to maximise clinical benefit and avoid wastage.
In 2008, we decided to look at our patterns of ED blood component use. This had not previously been studied in our ED, and more general information on the use of blood components and the characteristics of transfusion recipients was found to be limited [1] [2] [3] . A search of the literature using Medline revealed no information on the usage of blood components within UK EDs. We were also aware that in 2005, the 'Blood Safety and Quality' regulations were established stating that there must be full traceability of all aspects of the transfusion process from donor to recipient vein, maintained and available for 30 years [4] . Our performance in traceability had been poor over the previous couple of years however we had no information as to which components and which clinical conditions were involved. We also had no idea generally as to our pattern of blood component usage.
Background
The appropriate use of donor blood and its components, and effective alternatives is a much discussed public health issue, partly because of the increasing age of the population, the subsequent increase in demand for blood components and increasing costs of healthcare attributable to transfusion therapy [5] [6] . In 2001, the National Blood Stocks Management project reported 2.2% red cell concentrate (RCC) clinical wastage in 40 NHS hospitals [7] . In the USA, Wallace et al reported that 1.8 million (13.5%) of 13.3 million RCC units were wasted in 1994 (combined laboratory and clinical wastage) [8] . Reasons for this disparity may include differences in patterns of injury between the USA and UK or may reflect the improvements made in blood component utilisation over the intervening years. We were not able to find any information on other UK or international EDs' performance at tracing each blood component unit from donor to its final fate and therefore obviously no evidence for how to solve our potential poor traceability problem.
Baseline measurement
In September 2008, we performed a retrospective case note review to establish blood component usage and wastage within our ED in 2007 during which we had a total of 104,294 presentations. All adult patients (>12 years of age) presenting to the ED for whom blood components were ordered were enrolled. Albumin orders were excluded as albumin is not ordered on a patient-specific basis. Recycled units were those units returned to the blood bank with a secure 'cold chain' (within acceptable storage conditions while outwith blood bank control) and therefore able to be re-entered into stock for issue to another patient; discarded units were those units returned to blood bank whose cold chain was not secure and so could not be reissued. In cases where a unit of a blood component was issued by the blood bank and neither the unit nor the unitspecific identification tag was returned, this unit was recorded as unaccounted for.
Data was entered into a Microsoft Excel database (Microsoft Corporation, Redmond, Washington, USA) for statistical analysis.
Results were analysed by individual episodes of transfusion.
Median and IQR was calculated for non-parametric data and mean and SD for parametric data. 
Lessons and limitations
We have been able to demonstrate a 64% reduction in blood component ordering, a 39% reduction in component transfusion, a 68% increase in the proportion of ordered units that are transfused and a 96% reduction in unaccounted units, undoubtedly improving patient safety as a result of better emergency transfusion practice.
These improvements are immediately generalizable across the UK. The study was also retrospective in design; not all desired information was available for each patient episode and in some cases judgement had to be used when the indication for transfusion was unclear. However, data was available on the fate of every unit ordered by the ED during 2011 allowing our results to be a true representation of blood component usage in our ED.
We hope that with the identification of named ED transfusion link nurses and now excellent relationships between the ED and BTS, as well as a culture in our ED of blood transfusion audit and research, these improvements can be maintained and we can now focus on reducing wastage rates, which paradoxically, now we know what has happened to all of our units, have risen (previously these units were coded as unaccounted for). This will be tough, however since our review in June 2012 we have started to make inroads into this as well, using a similar ED teamwork approach to that demonstrated here. 
Conclusion

